
Q1 Dermatology Drug & Device Report: FDA Approvals & Pipeline Updates
The first quarter of 2025 saw significant developments in the dermatology specialty, with key decisions from the US FDA and a flurry of submissions, trial advancements, and regulatory actions from various organizations driving the pipeline forward. With a …